Cancer biology research

Cancer biology research Cancer Biology Research is an educational website dedicated to exploring the world of medical biology with a keen focus on cancer disease

Shope Papilloma Virus (SPV)👇The Shope Papilloma Virus (SPV), also known as Cottontail Rabbit Papillomavirus (CRPV), is a...
22/08/2025

Shope Papilloma Virus (SPV)👇
The Shope Papilloma Virus (SPV), also known as Cottontail Rabbit Papillomavirus (CRPV), is a DNA virus belonging to the Papillomaviridae family. It was first discovered in the 1930s by Dr. Richard E. Shope while studying horned lesions on wild cottontail rabbits. This virus played a foundational role in establishing the viral origin of certain types of cancer, making it historically significant in oncology and virology.

âś…Viral Structure and Genome
SPV is a non-enveloped virus with icosahedral symmetry and a circular double-stranded DNA genome. The genome is approximately 7.8 kilobases in size and contains early (E) and late (L) genes. The early genes (such as E6 and E7) are involved in viral replication and cell transformation, while the late genes (L1 and L2) encode structural capsid proteins. The L1 protein is particularly important for forming virus-like particles (VLPs) in vaccine research.

âś…Pathogenesis and Transmission
Shope Papilloma Virus primarily infects the epithelial cells of rabbits, causing the development of keratinized tumors known as papillomas. These tumors often appear on the skin, particularly around the head, neck, and limbs. Transmission occurs through direct contact or via insect vectors like ticks or mosquitoes, which introduce the virus into abrasions or wounds in the skin. If left untreated, some papillomas can undergo malignant transformation into squamous cell carcinomas.

âś…SPV as a Cancer Model
The Shope Papilloma Virus is one of the earliest known viruses linked to cancer in animals. It served as a pioneering model in cancer biology, demonstrating that viruses can cause tumors. Research on SPV laid the groundwork for understanding how human papillomaviruses (HPVs) contribute to cervical and other cancers. The E6 and E7 oncogenes of SPV are homologous to those found in high-risk HPV strains like HPV-16 and HPV-18.

âś…Immunological and Vaccine Insights
Studies involving SPV have been instrumental in the development of immunological strategies against papillomaviruses. Infected rabbits produce antibodies against viral proteins, particularly the L1 capsid protein, which has been exploited in the design of prophylactic vaccines. These findings directly influenced the development of the human HPV vaccines, such as Gardasil and Cervarix, which prevent cervical cancer and other HPV-associated diseases.

âś…Environmental and Evolutionary Considerations
The Shope Papilloma Virus has co-evolved with its rabbit hosts over millennia. Its restricted host range and slow evolutionary rate make it a valuable model for studying host-virus co-evolution, immune evasion, and viral persistence. Additionally, it provides insight into how environmental factors, such as UV radiation or co-infections, can influence viral oncogenesis and disease outcomes.

21/08/2025

What is immunotherapy?

20/08/2025

Therapeutic cancer cell reprogramming by derepressing nuclear pyruvate dehydrogenase

Nuclear acetyl-coenzyme A (CoA) constitutes a small fraction of the whole-cell pool, that regulates cell fate by locally providing histone acetylation substrate.

The researchers report a nucleus-specific acetyl-CoA regulatory mechanism that can be modulated to control cancer cell reprogramming.

They uncovered a nucleus-localized pyruvate dehydrogenase complex (nPDC), which is constitutively bound and repressed by nuclear protein ELMSAN1.

Pharmacological disruption of the ELMSAN1-nPDC interaction derepresses nPDC activity, synergizes with HDAC1/2 inhibitors, and therapeutically reprograms diverse cancer types to durably lose proliferation, stemness, and cell-of-origin identity.

https://www.cell.com/cell-metabolism/fulltext/S1550-4131(25)00265-7
https://sciencemission.com/Derepressing-nuclear-pyruvate-dehydrogenase

20/08/2025

What is a biopsy?

20/08/2025

What is the role of p53 in cancer?

20/08/2025

What is the tumor microenvironment?

20/08/2025

What is apoptosis?

20/08/2025

What are oncogenes?

19/08/2025

A new study reveals a signaling loop that drives metastasis in triple-negative breast cancer, discoveries about amylin receptor subunits could inform future drug design, and more this week in .

https://scim.ag/4mPai3T

Hypoxia-Induced Radiotherapy Resistance in Tumors👇✅Mechanism of Radiation-Induced DNA DamageRadiotherapy primarily kills...
19/08/2025

Hypoxia-Induced Radiotherapy Resistance in Tumors👇

âś…Mechanism of Radiation-Induced DNA Damage
Radiotherapy primarily kills cancer cells by inducing DNA damage through ionizing radiation. This process generates free radicals—such as hydroxyl (OH•) and hydrogen (H•) radicals—that cause DNA strand breaks, particularly double-strand breaks (DSBs), leading to cancer cell death.

âś…SPINK1-Mediated Antioxidant Defense
Hypoxic tumor cells secrete serine protease inhibitor Kazal-type 1 (SPINK1), which enhances the survival of nearby cancer cells. SPINK1 activates the epidermal growth factor receptor (EGFR) and the NRF2 antioxidant pathway in these cells, reducing the accumulation of radiation-induced free radicals and thereby decreasing DNA damage. This promotes cancer cell survival and contributes to radioresistance.

âś…Vascular Protection via Proangiogenic Factors
Hypoxic cancer cells also secrete proangiogenic cytokines such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF). These factors protect endothelial cells (ECs) from radiation damage, maintaining tumor vasculature and enabling continued nutrient and oxygen supply, which indirectly supports tumor regrowth after treatment.

✅HIF-1α and DNA Repair Enhancement
Hypoxia-inducible factor 1-alpha (HIF-1α) directly contributes to radioresistance by upregulating DNA-dependent protein kinase (DNA-PK), a critical enzyme involved in the repair of DNA double-strand breaks. This boosts the DNA repair capacity of cancer cells, allowing them to survive otherwise lethal radiation doses.


đź’ˇChen, Z., Han, F., Du, Y. et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Sig Transduct Target Ther 8, 70 (2023).

Hypoxia-Driven Mechanisms of Chemotherapy Resistance in Cancer👇✅IL-6 and miR-27a-Mediated Drug EffluxHypoxia enhances ch...
19/08/2025

Hypoxia-Driven Mechanisms of Chemotherapy Resistance in Cancer👇

âś…IL-6 and miR-27a-Mediated Drug Efflux
Hypoxia enhances chemotherapy resistance partly through inflammatory signaling. IL-6 promotes the expression of HIF-1α, which in turn upregulates microRNA-27a (miR-27a). This microRNA boosts the expression of P-glycoprotein (PGP), an efflux transporter that actively pumps chemotherapeutic drugs out of cancer cells, reducing intracellular drug concentrations and efficacy.

âś…Drug Transport and Efflux by Multidrug Resistance Proteins
HIF-1α also upregulates multidrug resistance protein 1 (MRP1) and breast cancer resistance protein (BCRP), further enhancing drug efflux. These transporters reduce the intracellular accumulation of chemotherapeutic agents, thereby diminishing their cytotoxic impact.

âś…Role of OLFM4 and Metabolic Reprogramming
Olfactomedin 4 (OLFM4), a HIF-1α target gene, contributes to chemoresistance by supporting cancer cell survival. Additionally, HIF-1α promotes the expression of pyruvate kinase M1 (PKM1), which enhances mitochondrial oxidative phosphorylation (OXPHOS), allowing cancer cells to maintain energy production and resist drug-induced stress even in low-oxygen environments.

âś…Autophagy and Resistance to Cell Death
Under hypoxia, cancer cells activate autophagy as a survival strategy and suppress BNIP3-mediated cell death—a key pathway normally activated by chemotherapy. This inhibition of programmed cell death helps tumor cells evade the cytotoxic effects of treatment.

✅Stemness and Resistance via TGF-β and GLI2
HIF-1α collaborates with transforming growth factor-beta (TGF-β) to activate GLI2 transcription through the SMAD3 signaling axis. GLI2 is associated with cancer stem cell traits and contributes to a more chemoresistant, self-renewing tumor cell population.

✅HIF-2α and Additional Resistance Pathways
HIF-2α further supports chemoresistance by activating the TGF-α/EGFR signaling pathway and increasing expression of cyclooxygenase-2 (COX-2), both of which are involved in survival and inflammation-related resistance mechanisms.

âś…Unclear Roles of CDD and SLC
Cytidine deaminase (CDD) and solute carrier (SLC) transporters also influence drug resistance, but their regulation under hypoxic conditions remains poorly understood and requires further investigation.
đź’ˇChen, Z., Han, F., Du, Y. et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Sig Transduct Target Ther 8, 70 (2023).

Address

Rabat

Alerts

Be the first to know and let us send you an email when Cancer biology research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share